Effects of carbamazepine and metabolites on IL-2, IL-5, IL-6, IL-10 and IFN-γ secretion in epileptic patients: the influence of co-medication.

Journal Title: Pharmacological Reports - Year 2011, Vol 63, Issue 1

Abstract

Carbamazepine is a widely used anticonvulsive agent. Its metabolic pathway leads not only to the major active metabolite, carbamazepine-10,11-epoxide, but also to minor terminal metabolites such as iminostilbene and acridine. Carbamazepine is usually well-tolerated, but it may lead to rare, but serious, hypersensitive reactions associated with hypereosinophilia. The mechanisms of hypersensitivity reactions to carbamazepine are still largely unknown, and the implications of the cell-mediated immune response (Th1 pathway) or the humoral immune response (Th2 pathway) are still not understood in these reactions. It is also unclear whether the parent drug or its subsequent metabolites are the primary trigger agent. In our study, we performed ex vivo experiments to evaluate the stimulation of cytokine secretion by carbamazepine, carbamazepine-10,11-epoxide, iminostilbene and acridine. IL-5, IL-6 and IL-10 were quantified as markers of the Th2 pathway, and IL-2 and IFN-γ were used as markers of the Th1 pathway. Blood samples (n=24) were obtained from epileptic patients routinely treated with carbamazepine alone or co-treated with lamotrigine or valproate. The concentrations of cytokines in the plasma were determined before and after 3 h stimulation with drugs. We found a significantly positive effect of co-treatment with valproate on the basal level of IL-5 (p<0.01) and IL-10 (p<0.05). IL-5 production increased only in blood stimulated with a high level of acridine (33 μM), whereas IL-6 production was less specifically stimulated (p<0.05). Because IL-5 is the most potent stimulating factor of the eosinophils, we suggest that the potential helper effect of valproate and acridine can lead to hypersensitive reactions to carbamazepine in the context of the humoral immune response.

Authors and Affiliations

Olivier Mathieu, Marie-Christine Picot, Philippe Gelisse, Hélène Breton, Pascal Demoly, Dominique Hillaire-Buys

Keywords

Related Articles

Central effect of crocin on penicillin-induced epileptiform activity in rats.

In the present study, the effects of separate and combined intracerebroventricular (icv) injections of crocin and diazepam were investigated on penicillin-induced epileptiform activity. In urethane-anesthetized rats, epi...

Introduction to in vitro estimation of metabolic stability and drug interactions of new chemical entities in drug discovery and development.

Determination of metabolic properties of a new chemical entity (NCE) is one of the most important steps during the drug discovery and development process. Nowadays, in vitro methods are used for early estimation and pred...

Neuroprotective potential of three neuropeptides PACAP, VIP and PHI.

Pituitary adenylate cyclase activating polypeptide (PACAP), vasoactiveintestinal peptide (VIP) and peptide histidine-isoleucine (PHI), are structurally related endogenouspeptides widely expressed in the central and perip...

Protective effect of alprazolam in acute immobilization stress-induced certain behavioral and biochemical alterations in mice.

Stress can be viewed as a cause of adverse circumstance that induces a wide range of biochemical and behavioral changes. Oxidative stress is a major contributor to the genesis of neurodegenerative and neuropsychiatric pr...

Dose-response relationship analysis of pregabalin doses and their antinociceptive effects in hot-plate test in mice.

The aim of this study was to determine the analgesic effects of pregabalin (a third-generation antiepileptic drug) using the acute thermal pain model (hot-plate test) in mice. Linear regression analysis was used to evalu...

Download PDF file
  • EP ID EP129499
  • DOI -
  • Views 85
  • Downloads 0

How To Cite

Olivier Mathieu, Marie-Christine Picot, Philippe Gelisse, Hélène Breton, Pascal Demoly, Dominique Hillaire-Buys (2011). Effects of carbamazepine and metabolites on IL-2, IL-5, IL-6, IL-10 and IFN-γ secretion in epileptic patients: the influence of co-medication.. Pharmacological Reports, 63(1), 86-94. https://europub.co.uk/articles/-A-129499